SRT-100™ Locator

PROVEN PERFORMANCE, SENSATIONAL RESULTS

At Sensus Healthcare, we are devoted to making a difference in the lives of people who suffer from non-melanoma skin cancer and unsightly keloid scarring. By designing and manufacturing safe and reliable state-of-the-art Superficial Radiation Therapy technology right here in the United States, we are providing compassionate dermatologists and oncologists around the world with a non-surgical treatment option that empowers them to cure patients without compromising patient confidence, dignity or quality of life.

The compact and mobile SRT-100™ is making this standard of care accessible to more patients. Not only does the SRT meet stringent safety requirements set by the FDA, UL and ISO/CE Mark certification, it is backed by accomplished, ethical leadership and scientific case studies that are testaments to the SRT’s exceptional performance.

VIEW OUR CASE STUDIES

https://www.sensushealthcare.com/wp-content/uploads/2015/09/logo.png

SENIOR LEADERSHIP TEAM

team-leadership https://www.sensushealthcare.com/wp-content/uploads/2015/09/team-green-leadership.jpg

MEDICAL ADVISORY BOARD

team-advisors https://www.sensushealthcare.com/wp-content/uploads/2015/09/team-green-advisors.jpg

BOARD OF DIRECTORS

team-directors https://www.sensushealthcare.com/wp-content/uploads/2015/09/team-green-directors.jpg

LEADERSHIP
TEAM

Joseph C. Sardano
Chief Executive Officer

A recognized leader in the healthcare industry, Joe Sardano has spent more than 30 years in management and marketing. He has a successful history of introducing and commercializing new technologies and services in many areas, including electronic brachytherapy, PET and PET/CT, SPECT, MRI, lithotripsy and digital radiography. Before joining Sensus Healthcare, Sardano held leadership and management roles at CTI Molecular Imaging, GE Medical Systems, Siemens Medical Systems, Elscint Inc and Toshiba America Medical Systems, among others.

Richard Golin
Executive Vice President
Oncology & International Sales

Richard Golin is an experienced healthcare business management and sales executive with an outstanding record in sales, operations and strategic planning. He has worked with portfolios valued at up to $85 million, and consistently exceeded sales and profit goals. Before joining Sensus Healthcare, Golin served as a senior executive with world-class corporations including Toshiba Medical Systems, Siemens, CTI Molecular Imaging and Hologic.

Arthur Levine
Chief Financial Officer

Arthur Levine has held senior finance roles in public and private companies in many industry sectors, including medical diagnostics, real estate and technology. Most recently, Levine served as Chief Accounting Officer of Trade Street Residential—a REIT—and played a key role in its IPO. He was also the Chief Financial Officer of IVAX Diagnostics, a publicly traded in-vitro diagnostics company that develops, manufactures and distributes diagnostic reagents, test kits and instrumentation worldwide. Levine worked at Ernst & Young in the United States and abroad. He received his Bachelor of Science from the Wharton School of the University of Pennsylvania and is a Certified Public Accountant.

Kal Fishman
Chief Technology Officer

Before joining Sensus Healthcare, Kal Fishman served as Vice President of Sales and Business Development with an artificial intelligence image diagnostics company. He has extensive P&L experience, along with a broad customer and vendor relationship base in the diagnostic medical imaging arena. Fishman previously served as a Global Product Manager and Six Sigma Black Belt at General Electric Medical Systems where he oversaw a successful $20MM global product line and led the Discovery™ LS PET/CT scanner e-campaign. During his tenure as Director of Sales and Marketing with Siemens Medical Systems, Fishman established and led the successful preclinical imaging division—achieving an 80 percent global market share and 100 percent CAGR throughout his leadership. Fishman holds an industry patent for the invention and commercialization of a handheld imaging device used in nuclear medicine and PET diagnostic imaging.

Steve Cohen
Executive Vice President
Strategic Initiatives & Dermatology

Steve Cohen has a strong history of sales and marketing in radiation therapy and diagnostic services. He is an accomplished entrepreneur and developer, skilled in shepherding new strategic business relationships to long-term recurring revenues and profits. In leadership roles with multinational organizations such as Technicare (J&J), Diasonics and Xoft, Inc., Cohen consistently delivered tangible successes.

MEDICAL
ADVISORY
BOARD

Clay J. Cockerell, MD
Medical Director

Clay J. Cockerell, MD, is a practicing dermatologist and dermatopathologist in Dallas, Texas. He is Director of Cockerell and Associates Dermpath Diagnostics Laboratories, a clinical professor of dermatology and pathology, and Director of Dermatopathology at the University of Texas Southwestern Medical Center.

Dr. Cockerell received his medical degree from Baylor College of Medicine in 1981. He has authored over 500 publications and has trained more than 40 dermatopathology fellows since 1988. He has lectured extensively across the United States and around the world.

Dr. Cockerell has held many leadership roles with the American Academy of Dermatology, including President (2005); Secretary-Treasurer (2001-2004); Board of Directors (1998-2004); Executive Committee (1998-2004); Assistant Secretary-Treasurer (1998-2001); and served on many of its committees. He also served as President of the Texas Dermatological Society (2003-2004).

Dr. Cockrell has served on the editorial board of numerous journals, including Assistant Editor for Journal of the American Academy of Dermatology (1993-1998). He is active in the American Academy of HIV Medicine, American College of Physician Executives, American Medical Association, American Society of Clinical Pathologists, American Society of Dermatology, College of American Pathologists, Dallas County Medical Society, International Academy of Pathology, International AIDS Society, International Society of Dermatology, Louisiana Dermatology Society, Masters Dermatologic Association, North American Clinical Dermatologic Society, Sir James Saunders Society, South Central Dermatology Society, Southwestern Dermatology Association, Texas Medical Association, Texas Society of Pathologists, United States and Canadian Academy of Pathology.

Mark Nestor, MD, Ph.D.
Clinical Director

Mark S. Nestor, MD, Ph.D. is the director of the Center for Cosmetic Enhancement® and the Center for Clinical and Cosmetic Research® in Aventura, Florida, and a voluntary associate professor of the Department of Dermatology and Cutaneous Surgery at the University of Miami, Leonard Miller School of Medicine. He is a past president of the American Society for Photodynamic Therapy, the International Society for Cosmetic and Laser Surgeons, and Florida Society of Dermatology and Dermatologic Surgery.

Dr. Nestor received his Ph.D. in Experimental Pathology and Immunology from UCLA and his medical degree from UCLA School of Medicine. He completed his residency in Dermatology at New York University.

Dr. Nestor is recognized as a world expert in skin cancer and cutaneous oncology, superficial radiation therapy, cutaneous laser surgery, photodynamic therapy, and the use of fillers and toxins in aesthetic medicine. He conducts FDA and non-FDA clinical trials on pharmaceuticals and devices used in clinical and aesthetic dermatology. He also serves as a consultant to numerous pharmaceutical and device companies—assisting them in the development of new medications, devices and cosmeceuticals.

Dr. Nestor also has authored more than 65 articles and book chapters and has delivered over 600 major presentations around the world. He has also directed over 50 meetings and symposia on relevant topics in the field of cosmetic dermatology, laser surgery and practice management. He also chairs the Annual South Beach Symposium.


 

Armand B. Cognetta, Jr., MD
Dermatology

Dr. Armand B. Cognetta, Jr., MD, has served as chairman and member of the Sensus Healthcare Medical Advisory Board since February 2011. As a recognized leader and innovator in his field, he provides clinical guidance and patient advocacy in the ongoing development of SENSUS Healthcare’s leading superficial radiotherapy product platform, the SRT-100™, and also leads the company’s multi-disciplinary medical advisory board to provide Sensus with clinical, ethical and scientific guidance regarding the development of future products and services. Joining Dr. Cognetta on the board, is a very distinguished and experienced panel of thought leaders on the treatment of skin cancer with photon x-ray technology. He serves as a member of the Scientific and Medical Advisory Committee of MELA Sciences, Inc. (also known as Electro-Optical Sciences, Inc.). Dr. Cognetta has practiced privately with Dermatology Associates of Tallahassee. He is a member of the American Academy of Dermatology, former president of the Florida Society of Dermatology, and past president of the Dermatology Photography Society.

Gary D. Monheit, MD
Dermatology

Gary Monheit, MD, is a native of Ossining, New York though he grew up in Tucson, Arizona. He graduated from the University of Arizona in 1966, and from the University of Colorado Medical School in 1970. He completed his medical internship at the University of Southern California, followed by a residency in dermatology at the University of Alabama at Birmingham in 1977—where he served as chief resident. Dr. Monheit also completed a fellowship in Moh’s micrographic surgery under Dr. Frederick Mohs, along with a training program in dermatologic surgery, at the University of Wisconsin in 1978.

Dr. Monheit is currently an associate clinical professor of dermatology at the University of Alabama at Birmingham and is the founder of Dermatology Associates, a private practice he established in 1978. He founded the first Mohs surgical practice for skin cancer in Alabama, along with a year-long fellowship training program in skin cancer that has been enhancing the skills of dermatological surgeons since 1986.

Dr. Monheit has lectured internationally on Mohs micrographic surgery, hair transplantation, chemical peeling, dermabrasion, soft tissue augmentation, laser surgery and cosmetic dermatologic surgery.

He has published over 50 articles in medical literature and chapters in books. From 1994 until 2007, Dr. Monheit was selected for the annual “Best Doctors in America.” He is currently conducting clinical research with dermal fillers, soft tissue augmentation and botulinum toxin for cosmetic usage and has served as a principle investigator for FDA trials of new products. His current practice interests include cosmetic dermatologic surgery, Mohs micrographic surgery and skin cancer. He is board certified in dermatology by the American Board of Dermatology and in cosmetic surgery by the American Board of Cosmetic Surgeons. He is a full Fellow in the American Academy of Dermatology, the American College of Mohs Surgery, The American Academy of Cosmetic Surgery and The American Society for Dermatologic Surgery. He is past President of AACS (2002) and ASDS (2006).

William I. Roth, MD
Dermatology

William I. Roth, MD, is a board-certified dermatologist who has been in practice for 34 years. His conviction in the superiority of superficial radiation therapy (SRT) for skin cancer treatment dates back to his joint practice with Victor H. Witten, MD—and Witten’s work with his past partner, Marion Sultzberger, MD.

Dr. Roth continues the legacy and breakthrough science of their innovations. Dr. Witten and Dr. Roth worked together demonstrating SRT excellent results for almost 15 years in Miami. The availability of new, safer and improved SRT delivery systems from Sensus Healthcare now helps Dr. Roth provide SRT in his private practice in Boynton Beach, Florida.

Dr. Roth is a clinical professor in The University of Miami School of Medicine Department of Dermatology, a Fellow of the American Academy of Dermatology and a member of the American Medical Association. Among his many past positions, he has served as President of the Florida Society of Dermatology and Dermatological Surgery and President of the Dade County Medical Association. Dr. Roth also served on the Board of Trustees of The Public Health Trust of Metropolitan Dade County (Jackson Memorial Hospital) from 1992 to 1993. He is pleased to serve on the Advisory Board of Sensus Healthcare.

Brian Berman, MD, Ph.D.

Professor Emeritus of Dermatology University of Miami Miller School;
Co-Director Center for Clinical and Cosmetic Research Skin and Cancer Associates, Aventura, FL

Dr. Brian Berman is Professor Emeritus of Dermatology and Dermatologic Surgery at The University of Miami Miller School of Medicine and has had the honor of serving as a member of the Board of Directors and is presently Vice President-Elect of the American Academy of Dermatology and the American Academy of Dermatology Association and Vice President of the American Dermatological Association. He has served as Professor of Dermatology and Internal Medicine at the University of Miami, Medical Director for Dermatology for inpatient and outpatients at Dade County’s Jackson Memorial Hospital, Professor of Dermatology and Vice-Chairman of the Department of Dermatology at The University of California, Davis, Chief of the Dermatology Service at the VA Medical Center, Martinez, CA, and Chairman of the Department of Dermatology at The Mount Sinai Medical Center in Miami Beach, Florida. He is past President and Founder of The National Association of Veterans Affairs Dermatologists, Chaired the Dermatology Field Advisory Group for The Department of Veterans Affairs, is a member of the nominating committee of the American Dermatological Association, Treasurer of the American Cutaneous Oncology Society, and serves on the Scientific Advisory / Editorial Boards of The European Journal of Dermatology, Journal of Cosmetic Dermatology, and SKINmed, Journal of Clinical and Aesthetic Dermatology, edited The Miami Review series and was a member of the Board of Trustees of the Sulzberger Institute for Dermatologic Education.

In addition to caring for patients at Skin and Cancer Associates in Aventura, FL, Dr. Berman also attends and teaches at the Miami Veterans Affairs Medical Center. As Co-Director of the Center for Clinical and Cosmetic Research he continues his broad-based clinical research program while focusing laboratory investigations on the study of the control of scarring. He has presented at over 300 local,regional, state, national and international Dermatologic Societies and meetings. He is the author of more than 250 peer-reviewed scientific and clinical articles, chapters and books, is the recipient of the Dean’s Senior Faculty Clinical Research Award from the University of Miami School of Medicine, was bestowed the “Scientist of the Year” Award from Sigma Xi the Science and Research Honor Society and is included in U.S. News and World Report’s “Best Doctors in America”.

Dr. Kevin Schewe

Dr. Kevin Schewe is a Board-Certified Radiation Oncologist and a Fellow of the American College of Radiation Oncology. Dr. Schewe has devoted his 30-year medical career and practice in the fight against cancer. He currently serves as Medical Director of Radiation Oncology at the Red Rocks Medical Center in Golden, Colorado (http://radiationoncologyatredrocks.com/). The Red Rocks Radiation Oncology Center was created by Dr. Schewe and is beautifully and warmly designed to feel more like a comfortable home for cancer patients rather than a traditional medical facility. Dr. Schewe serves as Chairman of National Cancer Survivors Day at the Red Rocks Center the first Sunday of every June and that event has become a highly-anticipated and joyful tradition in Jefferson County. He has been named to “5280 Top Docs” multiple years and is known as a strong advocate of the personalized treatment approach for each cancer patient entrusted to his care.

Dr. Schewe has also developed a premium line of skin care and cosmetic products that help to naturally heal, protect, repair and subsequently maintain not only the damaged skin of cancer patients, but also individuals who have experienced skin damage resulting from aging, dryness, UV exposure, other illnesses, and environmental pollution. These products are manufactured and sold by Dr. Schewe’s company Elite Therapeutics (http://www.elitetherapeutics.com/). Dr. Schewe also serves as Chairman of the Board of a publically-traded, microcap, renewable green-energy company called VIASPACE (http://viaspace.com/) which has a proprietary product called Giant King Grass that is a high-yielding biomass source that creates carbon-neutral bioenergy and biofuels.

Robert E. Beer, MD

Director of Balfour Dermatology, Dr. Beer; dermatologist and MOHS surgeon, is passionate about the treatment and detection of skin cancer. Dr. Beer was the first in California to adopt SRT, a non-surgical treatment for skin cancer.

He completed medical school at Baylor in Houston, Texas and his dermatology training at Columbia University in New York City. He completed his MOHS and Laser Fellowship in Kansas City, Missouri, additional training in Palm Springs, California.

For his leading role in dermatology, Dr. Beer was elected to serve as Chairman of Dermatology for John Muir Hospital in Walnut Creek.

Dr. Beer is a Fellow of American College of MOHS Micrographic Surgery and Cutaneous Oncology. Dr. Beer is board certified by the American board of Dermatology.

William M. Mendenhall, MD, FACR
Radiation Oncology

William Mendenhall, MD, FACR, received his medical degree from the University of Florida and completed his residency in radiation oncology at the University of Florida. His areas of interest include the treatment of patients with cancers of the head and neck—including the tongue, tonsils and larynx, gastrointestinal cancer and skin cancer. He also treats patients with brain tumors. Dr. Mendenhall was listed as one of “The 318 Top Cancer Specialists for Women” in Good Housekeeping magazine.

Dr. Mendenhall is a board-certified radiation oncologist at Shands Jacksonville in Jacksonville, Florida. He earned a medical degree from the University of South Florida College of Medicine in Tampa, Florida, and completed his residency in radiation oncology at the University of Florida College of Medicine in Gainesville, Florida.

Angela M. Abbatecola, MD, Ph.D.
Geriatrics

Angela M. Abbatecola, MD, Ph.D., has served as a contract researcher in the Scientific Direction at the Italian National Research Center on Aging (INRCA) in Ancona, Italy since 2009. She studied chemistry and obtained her Bachelor of Science from Syracuse University in Syracuse, New York in 1994 (summa cum laude). She then went on to earn her medical degree in 2001, followed by her Ph.D. in 2009 at the Second University of Naples in Naples, Italy—achieving the highest honor of recognition (summa cum laude) for both. Dr. Abbatecola is currently a member of two Italian committees in Rome focused on study protocols for older people in Italy—Geriatric Working Group at the AgenziaItalianadel Farmaco (AIFA) and the Scientific Board of the SocietàItaliana Geriatri Ospedalieri (SIGOS).

Dr. Abbatecola has authored more than 35 original papers, reviews, editorials, and chapters in diverse medical books. Her published work addresses many issues regarding the aging process and the difficulties often encountered when treating elderly patients. She continues to investigate ways to identify biomarkers for frailty syndrome, cognitive decline and sarcopenia.

Marta I. Rendon, MD
Dermatology

Marta Rendon, MD, is a board-certified dermatologist in private practice at The Rendon Center for Dermatology and Aesthetic Medicine in Boca Raton, Fla., and has served as a clinical associate professor in the Department of Dermatology at the University of Miami School of Medicine for more than 20 years. Dr. Rendon is the former Chairperson of the Department of Dermatology of Cleveland Clinic Florida. In addition, she serves as a clinical associate professor in the Department of Biomedical Sciences at Florida Atlantic University in Boca Raton, Florida, an affiliation of University of Miami School of Medicine.

Dr. Rendon serves as Procter & Gamble’s Head & Shoulders’ global celebrity dermatologist and has previously served as a speaker, advisor and physician trainer for 3M Pharmaceutical, Allergan, Galderma, GlaxoSmithKline, Janssen, Johnson & Johnson, L’Oreal, Merck, Procter & Gamble, Novartis, Ortho Dermatological, Pfizer, Salu, Schering, Sirrus Pharmaceutical, Unilever and Vichy.

Through skill, determination and compassion for patients suffering from skin disorders, Dr. Rendon has achieved a notable national and international reputation in her specialty. She has been featured on numerous television news and entertainment programs and many global magazines, including CNN, Telemundo, the Daily Buzz, Vogue, Allure, ELLE, Harper’s Bazaar and New Beauty.

With more than 25 years in the healthcare industry, Dr. Rendon is a world-renowned researcher who specializes in psoriasis, eczema, alpha-hydroxy acids and the effects of cosmetics on the skin. Dr. Rendon’s specialty interests include cosmetic dermatology, laser surgery, wound care, dermatologic surgery, dermatologic manifestations of systemic disease and phototherapy (treatment with ultraviolet light), along with the innovative treatment of pigmentary disorders experienced by patients of color. Dr. Rendon provides surgery for skin cancer, laser skin resurfacing, skin smoothing with filler agents, laser hair removal, laser removal of tattoos, hyperpigmented lesions, phototherapy and wound-healing techniques. In February 2012, she was honored with the Greater Boca Raton Chamber of Commerce’s coveted Diamond Award.

David J. Goldberg, MD, JD

David J. Goldberg, MD, JD is recognized nationally and internationally for his innovative work with skin lasers, cosmetic dermatology and non-invasive facial and body rejuvenation techniques. A board-certified dermatologist who has been in practice since 1985, he has treated patients and taught doctors throughout the world in the use of these cutting-edge technologies. Under his direction, Skin Laser & Surgery Specialists of New York and New Jersey has been a pioneer in making skin laser and cosmetic dermatology technologies available to the public.

Dr. Goldberg earned his medical degree from Yale University. He completed his dermatology residency and dermatologic surgical fellowship at New York University Medical Center. He is a clinical professor and former director of Mohs Surgery and Laser Research in the department of Dermatology at NY’s Icahn School of Medicine at Mount Sinai..

Dr. Goldberg has published over 160 academic papers and has contributed to over 15 academic textbooks. He has authored textbooks on laser dermatology, laser hair removal, laser facial rejuvenation, photodamaged skin, skin wrinkle fillers, acne, rosacea, unwanted fat and cellulite . He has also co-authored two books for the general public: Light Years Younger and Secrets of Great Skin.

Dr. Goldberg is active in professional societies and was elected president of the American Society for Lasers in Medicine & Surgery. He has also served as chairperson of the Ethics Committees of the American Academy of Dermatology, the American Society for Lasers in Medicine and Surgery and the American Society for Dermatologic Surgery. He has sat on the board of directors of the American Academy of Dermatology, the American Society for Lasers in Medicine and Surgery, the American Society for Dermatologic Surgery and the International Society for Dermatologic Surgery. He has also served as a co-vice-president of the Skin Cancer Foundation.

Dr. Goldberg was the first recipient of the prestigious Leon Goldman award, named after the founder of laser surgery. Additionally, Dr. Goldberg was named one of the “Top Ten Laser Surgeons in the U.S.” by Self magazine, one of the “Best Doctors in America” by Woodward/White, Inc., a “Best Doctor in America” by Best Doctors Inc. and one of the “Best Dermatologists in New Jersey” by New Jersey Monthly.
Dr. Goldberg has always been eager to advance the skill levels of his colleagues. He has an active fellowship Program at his practice that draws the “best of the best” dermatologists and Physician Assistants, many of whom join Skin Laser & Surgery Specialists of New York and NY and NJ after their fellowship is complete.

Lastly, his legal background and expertise in Health Care Law (he has taught Health Care Law at NY’s Fordham Law School for over 15 years) puts Dr. Goldberg at the forefront in understanding the economic, legal and ethical issues of today’s health care and dermatology delivery systems.

Michael H. Gold, MD, FAAD

Dr. Michael H. Gold is the founder of Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser & Rejuvenation Center, and Tennessee Clinical Research Center located in Nashville, Tennessee. Dr. Gold is also Clinical Assistant Professor at Vanderbilt University School of Nursing and Adjunct Assistant Professor at Meharry Medical College, School of Medicine also in Nashville, Tennessee. He is also a Physician Assistant Student Preceptor of Wake Forest School of Medicine in Winston Salem, NC. He is a Visiting Professor of Dermatology for Huashan Hospital, Fudan University in Shanghai, China (11/2006), Guangdong Provincial People’s Hospital, Guangzhou, China, as well as Visiting Professor of Dermatology at Number One Hospital of China Medical University (11/2008) in Shenyang, China. Visiting Professor Rongjun Hospital, Jiaxing, China, 2016. Additionally, he is Visiting Professor of Plastic Surgery, First People’s Hospital of Foshan, Guangzhou, China and The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang. In addition, he is Visiting Professor of Plastic Surgery, The People’s Hospital of Hunan Province.

Dr. Gold is a board-certified dermatologist and cosmetic surgeon who oversees the various facets of the Gold Skin Care Center’s operations: a combination of medical and surgical dermatology, cosmetic dermatology, aesthetic services, and research endeavors. Dr. Gold has earned a national and international reputation for providing patients with leading-edge technological advances and has expertise in all facets of dermatology and aesthetic care. The Tennessee Clinical Research Center is one of the leading dermatologic research institutions in the U.S. Dr. Gold is the author of over 300 published scientific articles, and 35 textbook chapters. He is the editor of two textbooks on photodynamic therapy and global use of PDT. Dr. Gold works as an associate editor with the majority of dermatology journals and actively contributes to the medical literature with his colleagues from around the world. In 2016, he became the Editor-in-Chief of the Journal of Cosmetic Dermatology.

Dr. Gold speaks on national and international fronts, focusing on dermatology issues related to the use of lasers and energy-based devices, as well as the use of fillers and toxins in aesthetic and cosmetic dermatology. He has spoken on Practice Management issues in dermatology for almost 30 years.

He lectures in venues around the world and is a sought-after contributor to educational meetings globally.

Dr. Gold is an active member of many of the leading dermatology and laser specialty societies in the U.S. and around the world. He is the founder and past President of the Dermatologic & Aesthetic Surgery International League (DASIL), whose mission is to teach dermatology and dermatologic surgery all over the world in a non-profit setting. This society has become one of the fastest-growing international dermatologic societies because of its core beliefs of teaching and transparency. Dr. Gold oversees the DASIL meeting, which attracts 150 faculty members, and upwards of serval thousand attendees from more than 40 countries. DASIL is primed to be the international dermatologic surgery society. He is a founding member and current President of the 5-Continent-Congress, one of the leading global aesthetic congresses. These meetings held in Barcelona, attract over 150 faculty and up to 1200 attendees. It has become one of the leading aesthetic meetings in the world. In addition, Dr. Gold is the President of the Symposium for Cosmetic Advances & Laser Education (SCALE), which is part of the Tennessee Society for Laser Medicine and Surgery. The meeting, which began 12 years ago, as an effort to educate and teach the proper use of lasers and injectables in the community. Since its onset, SCALE has grown in stature and regarded as one of the most influential aesthetic and dermatology meetings in the U.S. SCALE’s base is in Nashville, Tennessee and attracts an incredible faculty year after year.

 

 

BOARD OF
DIRECTORS

Joseph C. Sardano
Chief Executive Officer

A recognized leader in the healthcare industry, Joe Sardano has spent more than 30 years in management and marketing. He has a successful history of introducing and commercializing new technologies and services in many areas, including electronic brachytherapy, PET and PET/CT, SPECT, MRI, lithotripsy and digital radiography. Before joining Sensus Healthcare, Sardano held leadership and management roles at CTI Molecular Imaging, GE Medical Systems, Siemens Medical Systems, Elscint Inc and Toshiba America Medical Systems, among others.

bill

Bill McCall
Financial Advisor

Bill McCall has served as a financial advisor and portfolio manager for over 43 years and is currently a Managing Director of Heritage Advisory Group, a financial advisory practice of Ameriprise Financial Services Inc. Other business activities include Managing Partner of Investors Capital Alliance LLC, a consulting company; CEO of WMW Partners LLC, a holding company; member of Pandora Mineral Resources LLC and Board member of Cherokee Farm Partners Inc., an entity of the University of Tennessee Research Foundation. Bill holds a Bachelor of Science Degree in Business Administration with a concentration in Finance and Marketing from the University of Tennessee and he received a Chartered Wealth Advisor designation from Michigan State University.

bill

Anthony B. Petrelli

Mr. Petrelli received his BS in Business (Finance) and his Masters of Business Administration (MBA) from the University of Colorado and a Masters of Arts in Counseling from Denver Seminary. He began his career in 1972 and since that time has managed the Corporate Finance departments for Bosworth, Sullivan & Co., Hanifen,Imhoff, Inc. and his current position at NTB Financial Corporation. Mr. Petrelli has served on numerous regulatory and industry committees including service on the FINRA Corporate Finance Committee, the NASD Small Firm Advisory Board, the FINRA Fixed Income Committee, the FINRA District Surveillance Committee, District 3 and as the Chairman of the FINRA District Business Conduct Committee, District 3, FINRA Statutory Disqualification Board and as a FINRA Arbitrator and as a member of the Task Force on Future of Shared State and Federal Securities Regulation, North American Securities Administrators Association, Inc. (NASAA) among others. Mr. Petrelli has also served as the Chairman of the Regional Investment Bankers Association. Mr. Petrelli has been involved in many aspects of the securities industry. He has had extensive experience in his 40 years in the areas of operations, sales, trading, management of sales, underwriting and corporate finance.

John Heinrich, PhD
Director

John Heinrich has been involved in the development and management of a wide range of diagnostic imaging, therapeutic, medical diagnostic and scientific instrument companies for more than 25 years. He played a key role in the development of mobile MRI systems in the early 1980s and served as Vice President of MRI products at Technicare Corporation. Over the past 15 years, his responsibilities have included serving as: President and Chief Operating Officer of Technomed International USA Inc., a leading developer and marketer of therapeutic technology; President and Chief Operating Officer of Summit World Trade, a diversified group of health care and technology companies; President and Chief Executive Officer of Otsuka Electronics USA Inc., a developer and marketer of medical and scientific equipment; and President and Chief Operating Officer of Meretek Diagnostics Inc., a developer and marketer of medical diagnostics. Dr. Heinrich was responsible for the sales of Otsuka’s medical and scientific equipment businesses to Elscint Ltd. and Varian Instruments, respectively, along with the acquisition of Cambridge Isotope Laboratories and Meretek Diagnostics. He is also a cofounder and director of Acuitas Medical, a developer of unique MRI software, and managing partner of Revolution NMR, LLC and Kansas Analytical Services, LLC.

Sam O’Rear
Director

Sam O’Rear has 40 years of experience in the healthcare industry as a clinician, a sales and marketing director, vice president, general manager, owner and principal in several healthcare services businesses. His experience as clinician in the ancillary hospital services was garnered primarily in the UAB Health System (1970-74). From 1974 to1990, he held sales and marketing positions in Siemens and GE Healthcare. O’Rear rose from management posts in sales, financing, asset management and marketing to vice president and general manager of X-Ray Business.

O’Rear left GE to become the chief operating officer for Medical Imaging Centers of America in 1990. That year, he also founded The Innovation Group, Inc. (TIGI). Over the years, he has acquired several consulting firms to expand TIGI into a multi-partner healthcare consultancy. Today, TIGI provides commercialization services to a client base extending from start-ups to Fortune 500 companies represented by GE, Philips, Toshiba, Xerox, Roche, HCA, VHA, MedAssets, Compass Group, Cobalt, Sysmex, Cobalt, etc.

O’Rear holds a Bachelor of Science in Chemical Engineering and a Master’s in Psychology. He is the senior partner of Total Innovation Group, Inc., and is an investor, principal and board member in several start-ups in the healthcare industry (Data Advantage, Remcare, Sensus, UP Labs).

icon-knife

No Cutting

icon-human

No Pain

icon-clock

No Downtime

icon-head

No Scarring

full-width-srt-100-machine-1024x833